稳心颗粒治疗冠心病室性期前收缩82例临床观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical Observation on Efficacy of Wenxin Granule to Treat Ventricular Contraction of Coronary Heart Disease in 82 Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察稳心颗粒治疗冠心病室性期前收缩的疗效和安全性。方法:对符合入选标准的冠心病室性期前收缩患者,采用自身对照、开放单一治疗试验设计方案,给予稳心颗粒9 g,3次/d,温开水冲服,连续服药8周,观察疗效和安全性。结果:24 h动态心电图室性期前收缩次数由入选时的(6 858±734)次减少至8周时的(2 640±438)次,减少幅度61.5%。显效率31.3%;有效率51.3%;无效率16.5%;总有效率83.5%。结论:稳心颗粒对冠心病室性期前收缩具有确切的抗心律失常的作用,依从性好,安全可靠。

    Abstract:

    To observe curative effect and safety of Wenxin Granule to treat ventricular contraction of coronary heart disease. Methods: In a self-control, open monotherapy trial, patients were given 9 g Wenxin Granule, 3 times a day, for 8 weeks. Results: The occurrence of ventricular contraction observed in 24 h dynamic ECG was decreased from (6 858±734) before treatment to (2 640±438) after 8-week treatment, ie. decreased by 61.5%. Significant effective rate was 31.3%, effective rate was 51.3%, ineffective rate was 16.5%, total effective rate was 83.5%. Conclusion: Wenxin Granule is a safe medicure to treat ventricular contraction of coronary heart disease.

    参考文献
    相似文献
    引证文献
引用本文

雷 蕾.稳心颗粒治疗冠心病室性期前收缩82例临床观察[J].世界中医药,2014,9(07).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-01-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-07-17
  • 出版日期:
文章二维码